admin, Author at PsyNews.com

Home Authors Posts by admin

1752 POSTS 0 COMMENTS

https://psynews.com

Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality,...

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and...

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in...

Disposition of Common Shares of Small Pharma Inc.

GH Research Provides Updates and Guidance on its Clinical Development Program...

PT446 – Decolonization, Interconnection, and the Medicalization of Mysticism

Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT...

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY...

So, You’ve Become a Psychedelic-Informed Practitioner. Now what?

12 3...176 Page 1 of 176

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin

Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality,...

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and...

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in...

Disposition of Common Shares of Small Pharma Inc.

GH Research Provides Updates and Guidance on its Clinical Development Program...

PT446 – Decolonization, Interconnection, and the Medicalization of Mysticism

Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT...

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY...

So, You’ve Become a Psychedelic-Informed Practitioner. Now what?

EDITOR PICKS

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

POPULAR CATEGORY